Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma
This research trial studies late effects after treatment in patients with previously diagnosed high-risk neuroblastoma. Studying late effects after treatment may help to decide which treatments for high-risk neuroblastoma are better tolerated with less side effects over time.
Research Base: Children's Oncology Group
NCT ID: NCT03057626
NCI Protocol Number: COG-ALTE15N2
Status: Active, not recruiting
For more information see ClinicalTrials.gov
Interventions
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
- Quality-of-Life Assessment
Condition
Recurrent Neuroblastoma, Stage 2A Neuroblastoma, Stage 2B Neuroblastoma, Stage 3 Neuroblastoma, Stage 4 Neuroblastoma, Stage 4S Neuroblastoma
Trial Type
Supportive Care/Symptom Management/PROs
See a list of participating sites on ClinicalTrials.gov